Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole in Advanced Breast Cancer
NCT00544986Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2005
- Primary completion
- Nov 2007
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
01
Overview
Phase 4, open-label, single-arm trial of anastrozole in breast cancer, sponsored by AstraZeneca. Primary endpoints: Tolerability (Safety), Time to Tumor Progression and 2 more. Started Jun 2005; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00544986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544986.